Literature DB >> 3639118

Analysis of prostatic bud induction by brief androgen treatment in the fetal rat urogenital sinus.

H Takeda, I Lasnitzki, T Mizuno.   

Abstract

The androgen dependency of prostatic bud formation in fetal rat urogenital sinuses was studied using brief treatments with androgen, and the incorporation of androgens by the sinus mesenchyme was followed by steroid autoradiography. Urogenital sinuses from 16.5-day fetuses of both sexes were grown in organ culture and treated with androgens for periods ranging from 4 to 72 h and then transferred to control medium. A minimum treatment of 24 h was required to induce prostatic buds in male sinuses and of 36 h in all female sinuses. This difference in response disappeared after more prolonged treatment. In both sexes the number of prostatic buds increased with the time of exposure to androgens. Prostatic bud formation continued for 24-36 h after transfer to control medium. Steroid autoradiographic analysis showed that the labelled androgen was concentrated in the mesenchymal nuclei. The rate of incorporation rose steeply during the first 12 h and then more slowly. After transfer to control medium the amount of labelled androgen decreased rapidly to half within 12 h and then decreased more slowly. In the competition experiments a 200-fold excess of unlabelled testosterone or dihydrotestosterone in the labelling medium greatly reduced the nuclear labelling with [3H]testosterone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3639118     DOI: 10.1677/joe.0.1100467

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  16 in total

1.  Androgen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathways.

Authors:  Yongbing Pu; Liwei Huang; Lynn Birch; Gail S Prins
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

Review 2.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

3.  Distribution and regulation of progesterone receptor in the urogenital tract of the chick embryo. An immunohistochemical study.

Authors:  J M Gasc
Journal:  Anat Embryol (Berl)       Date:  1991

4.  PI3K/mTOR signaling regulates prostatic branching morphogenesis.

Authors:  Susmita Ghosh; Hiu Lau; Brian W Simons; Jonathan D Powell; David J Meyers; Angelo M De Marzo; David M Berman; Tamara L Lotan
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

Review 5.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

Review 6.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

Review 7.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

Review 8.  Prostate Organogenesis.

Authors:  Jeffrey C Francis; Amanda Swain
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

9.  A comparison of prostatic development in xenografts of human fetal prostate and human female fetal proximal urethra grown in dihydrotestosterone-treated hosts.

Authors:  Gerald R Cunha; Mei Cao; Omar Franco; Laurence S Baskin
Journal:  Differentiation       Date:  2020-07-14       Impact factor: 3.880

Review 10.  Stromal androgen receptor in prostate development and cancer.

Authors:  Mandeep Singh; Ruchi Jha; Jonathan Melamed; Ellen Shapiro; Simon W Hayward; Peng Lee
Journal:  Am J Pathol       Date:  2014-08-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.